Annual report pursuant to section 13 and 15(d)

SEGMENT REPORTING

v2.4.0.8
SEGMENT REPORTING
12 Months Ended
Dec. 31, 2013
SEGMENT REPORTING [Abstract]  
SEGMENT REPORTING
NOTE 16
SEGMENT REPORTING

In accordance with ASC 280, “Segment Reporting”, we define an operating segment as a business activity:

· from which we may earn revenue and incur expenses;
· whose operating results are regularly reviewed by the Chief Operating Officer (our Chief Operating Decision Maker) to make decisions about resources to be allocated to the segment and assess its performance; and
· for which discrete financial information is available.

We currently have two reporting segments, Treatment and Services Segments, which are based on a service offering approach.  This, however, excludes corporate headquarters, which does not generate revenue, and our discontinued operations, which includes all facilities as discussed in “Note 7 – Discontinued Operations and Divestitures.”

The table below shows certain financial information of our reporting segments for 2013 and 2012 (in thousands).

Segment Reporting as of and for the year ended December 31, 2013
 
   
 
 
 
Treatment
 
   
Services
 
 
Segments
Total
 
   
Corporate
And Other
   
(2) 
 
Consolidated
Total
 
Revenue from external customers
 
$
35,540
 
   
$
38,873
 
 
$
74,413
   
(3) 
 
$
       
$
74,413
 
Intercompany revenues
   
1,179
 
     
77
 
 
 
1,256
         
¾
         
¾
 
Gross profit
   
5,574
 
     
4,242
 
 
 
9,816
         
¾
         
9,816
 
Interest income
   
¾
 
     
¾
 
 
 
¾
         
35
         
35
 
Interest expense
   
42
 
     
(3
)
 
 
39
         
723
         
762
 
Interest expense-financing fees
   
¾
 
     
¾
 
 
 
¾
         
132
         
132
 
Depreciation and amortization
   
3,045
 
     
990
 
 
 
4,035
         
91
         
4,126
 
Segment loss
   
(8,198
)
 
(6) 
   
(20,042
)
 
(6) 
     
(28,240
)
       
(6,231
)
       
(34,471
)
Segment assets(1)
   
49,978
         
11,951
           
61,929
         
29,671
   
(4) 
    91,600  
Expenditures for segment assets
   
477
         
466
           
943
         
1
         
944
 
Total debt
   
106
         
¾
           
106
         
14,142
   
(5) 
   
14,248
 
 
                                                         
Segment Reporting as of and for the year ended December 31, 2012
             
 
 
Treatment
       
Services
         
Segments
Total
       
Corporate
And Other
   
(2) 
 
Consolidated
Total
 
Revenue from external customers
 
$
45,882
       
$
81,627
         
$
127,509
   
(3) 
 
$
       
$
127,509
 
Intercompany revenues
   
1,785
         
845
           
2,630
         
¾
         
¾
 
Gross profit
   
9,268
         
6,536
           
15,804
         
¾
         
15,804
 
Interest income
   
¾
         
¾
           
¾
         
41
         
41
 
Interest expense
   
9
         
12
           
21
         
797
         
818
 
Interest expense-financing fees
   
¾
         
¾
           
¾
         
107
         
107
 
Depreciation and amortization
   
4,448
         
949
           
5,397
         
73
         
5,470
 
Segment profit (loss)
   
2,951
         
1,474
           
4,425
         
(7,574
)
       
(3,149
)
Segment assets(1)
   
75,405
         
36,120
           
111,525
         
28,166
   
(4) 
   
139,691
 
Expenditures for segment assets
   
263
         
145
           
408
         
4
         
412
 
Total debt
   
85
         
5
           
90
         
14,106
         
14,196
 

 
(1)
Segment assets have been adjusted for intercompany accounts to reflect actual assets for each segment.

 
(2)
Amounts reflect the activity for corporate headquarters, not included in the segment information.

 
(3)
The consolidated revenues included the CH Plateau Remediation Company (“CHPRC”) revenue of $19,922,000 or 26.8% and $24,652,000 or 19.3%, for 2013 and 2012, respectively, of our total consolidated revenue from continuing operations.
 
(4)
Amount includes assets from our discontinued operations of $4,481,000 and $2,113,000, as of December 31, 2013 and 2012, respectively.

 
(5)
Net of debt discount of ($223,000) based on the estimated fair value at issuance of two Warrants and 90,000 shares of the Company’s Common Stock issued on August 2, 2013 in connection with a $3,000,000 promissory note entered into by the Company and Messrs. William Lampson and Robert L. Ferguson.  See Note 8 – “Long-Term Debt – Promissory Note and Installment Agreement” for additional information.”

 
(6)
Includes goodwill impairment charge of $13,691,000 for the Treatment Segment and $14,165,000 for the Services Segment.